BioCentury
ARTICLE | Company News

AmVac, Bayer to develop influenza vaccine

June 13, 2008 1:20 AM UTC

AmVac (Zug, Switzerland) and Bayer (Xetra:BAY) partnered to research and develop an influenza vaccine using antigens that Bayer's Icon Genetics GmbH subsidiary will produce in tobacco plants. The vacc...